GGrantIndex
Sort

172,184 grants matching inflammation

Translational Evaluation of PET Radiotracers

$2,110,573
Robert Innis · National Institute Of Mental Health · ZIA · FY2025 · MH

Role of Eosinophils in Airway Inflammation and Remodeling

$2,110,341
Nizar N Jarjour · University Of Wisconsin-Madison · P01 · FY2014 · HL

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$2,109,490
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease

$2,109,352
Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES

A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia

$2,108,843
David G. Nathan · Dana-Farber Cancer Inst · P50 · FY2015 · HL

Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments

$2,108,243
Martha C Sola-Visner · Boston Children'S Hospital · P01 · FY2018 · HL

Proteogenomics for Organ Transplantation: Prediction, Diagnosis, Intervention

$2,108,067
Michael Abecassis · Northwestern University At Chicago · U01 · FY2011 · AI

SCOR in Pathobiology of Lung Development

$2,107,968
Children'S Hospital Med Ctr (Cincinnati) · P50 · FY2003 · HL

The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory

$2,107,225
Rima F Kaddurah-Daouk · Duke University · U01 · FY2025 · AG

Airway inflammation and HLA-G in asthma

$2,107,018
Steven R White · University Of Chicago · U19 · FY2013 · AI

Pro-inflammatory cytokine lowering anti-inflammatory drugs

$2,106,657
Nigel H. Greig · National Institute On Aging · ZIA · FY2022 · AG

Genotypic Determinants of Aspirin Response in High-Risk

$2,105,931
Johns Hopkins University · U01 · FY2002 · HL

Roles Of Brain Neuroimmune System In Neurodegeneration

$2,104,992
Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES

Immunobiology, molecular virology and countermeasures of highly pathogenic viruses

$2,104,975
Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Shaping Antiviral Immunity by the Inflammatory, Regulatory and Tissue Environment

$2,104,058
E. John Wherry · Wistar Institute · U19 · FY2009 · AI

Cellular Mechanisms and Therapeutic Potential of NR4A1 in Pain Resolution

$2,103,564
Temugin Berta · University Of Cincinnati · RF1 · FY2024 · NS

Arterial Dysfunction: Basic and Clinical Mechanisms

$2,103,499
Thomas Michel · Brigham And Women'S Hospital · P01 · FY2009 · HL

Characterization of the molecular mechanisms of LC3-associated phagocytosis and its role in disease pathogenesis

$2,102,717
Jennifer Martinez · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

Characterization of novel genes encoded ty RNA and DNA viruses

$2,102,641
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI

CHEMISTRY AND BIOLOGY OF HEPARAN SULFATE

$2,102,516
Umesh Ramanlal Desai · Virginia Commonwealth University · P01 · FY2013 · HL

Emulating Immune Dysregulation by Trisomy 21 in a Multi-Organ-on-a-Chip System

$2,101,852
Kambez Hajipouran Benam · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL

Cell surface proteolysis in development, tissue repair, and malignancy

$2,101,834
Thomas H Bugge · National Institute Of Dental & Craniofacial Research · ZIA · FY2016 · DE

Integrated heart-liver-vascular systems for drug testing in human health and dise

$2,101,473
Gordana Vunjak-Novakovic · Columbia University Health Sciences · UH3 · FY2016 · EB

Center for Addiction and Disease Risk Exacerbation

$2,101,337
Peter M. Monti · Brown University · P20 · FY2022 · GM

Avanzando Caminos (Leading Pathways): The Hispanic/Latino Cancer Survivorship Cohort Study.”

$2,100,604
Frank J Penedo · University Of Miami Coral Gables · UH3 · FY2025 · CA